Searched for
BIOPHORE INDIA
High costs of orphan drugs: Patients pay the price for policy hurdles in IndiaIndia manufactures APIs for over 400 FDA-approved orphan drugs, but patients face high costs due to Indian pharmaceutical companies' reluct...- How a complicated regulatory landscape hurting startups selling food, clothes & wellness products made from hempHemp gets a bad rap due to its infamous cousin marijuana. To make matters worse, they look somewhat alike. They both belong to the cannabis...
- Akums enters into a pact with Leiutis, Biophore for bringing therapeutics to IndiaThis association is set to bring succour in therapy areas of CNS disorders, pain management, and hormonal disorders, where there is a gap i...
- Zenara Pharma gets CDSCO nod to launch Covid antiviral Paxlovid in IndiaThe approval by the Central Drugs Standard Control Organization (CDSCO) has been granted under the emergency authorization route considerin...
- Biophore India receives licences from MPP to market molnupiravirThe licences are applicable for both active pharmaceutical ingredients (API) and finished product in capsules form. It enables the company ...
- Zenara Pharma receives DCGI approval to manufacture, sell Favipiravir tabletsZenara Pharma, a fully owned subsidiary of Biophore India Pharmaceuticals, announced that it has received approval from the Drugs Controlle...
- Drug firms get DGCI nod for Covid drug favipiravir despite inconclusive studyOn Tuesday, Hyderabad-based Biophore India Pharmaceuticals said it has received approval from the Drug Controller General of India (DGCI) t...
- Hyderabad based Biophore India gets DCGI nod to manufacture COVID drug FavipiravirFavipiravir is an antiviral agent that was initially discovered and developed because of its activity against another RNA (ribonucleic acid...
- RPG Life Sciences inks pact to acquire Sun Pharma's 7 brandsThe company believes these brands have a huge potential to grow and are a perfect fit to its current portfolio and in line with the long-te...
Load More
